Uveal melanoma and BRCA1/BRCA2 genes: A relationship that needs further investigation

Journal of Clinical Oncology

Volumn 29, Issue 34, 2011, Pages

  Cruz, Cristina ^a   Teule, Alexandre ^a   Caminal, Josep M ^b   Blanco, Ignacio ^a   Piulats, Josep M ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHOROID MELANOMA; EYE SURGERY; FAMILY HISTORY; FEMALE; FOLLOW UP; FRAMESHIFT MUTATION; HISTOPATHOLOGY; HUMAN; LARGE CELL LYMPHOMA; LIVER METASTASIS; MALE; MASTECTOMY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SECOND CANCER; TRIPLE NEGATIVE BREAST CANCER; UVEA MELANOMA;

ADOLESCENT; ADULT; FEMALE; GENES, BRCA2; HUMANS; MALE; MELANOMA; MUTATION; PEDIGREE; UVEAL NEOPLASMS;

EID: 83355166963     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.8828     Document Type: Article

References (24)

1. Virgili G, Gatta G, Ciccolallo L, et al: Incidence of uveal melanoma in Europe. Ophthalmol 114:2309-2315, 2007
2. Singh AD, Topham A: Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmol 110:956-961, 2003 (Pubitemid 36560496)
3. Abdel-Rahman MH, Pilarski R, Ezzat S, et al: Cancer family history characterization in an unselected cohort of 121 patients with uveal melanoma. Fam Cancer 9:431-438, 2010
4. Buecher B, Gauthier-Villars M, Desjardins L, et al: Contribution of CDKN2A/P16 (INK4A), P14 (ARF), CDK4 and BRCA1/2 germline mutations in individuals with suspected genetic predisposition to uveal melanoma Fam Cancer 9:663-667, 2010
5. Bergman L, Nilsson B, Ragnarsson-Olding B, et al: Uveal melanoma: A study on incidence of additional cancers in the Swedish population. Invest Ophthalmol Vis Sci 47:72-77, 2006 (Pubitemid 46780797)
6. Scélo G, Boffetta P, Autier P, et al: Associations between ocular melanoma and other primary cancers: An international population-based study. Int J Cancer 120:152-159, 2007 (Pubitemid 44901930)
7. Caminal JM, Martínez J, Arias LL, et al: Multiple neoplasms in patients with uveal melanoma. Arch Soc Esp Oftalmol 82:535-540, 2007
8. Van Raamsdonk CD, Griewank KG, Crosby MB, et al: Mutations in GNA11 in uveal melanoma. N Engl J Med 363:2191-2199, 2010
9. Abdel-Rahman MH, Pilarski R, Massengill JB, et al: Lack of GNAQ germline mutations in uveal melanoma patients with high risk for hereditary cancer predisposition. Fam Cancer 10:319-321, 2011
10. Easton D: Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310-1316, 1999
11. Easton DF, Steele L, Fields P, et al: Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 61:120-128, 1997 (Pubitemid 27323331)
12. Sinilnikova OM, Egan KM, Quinn JL, et al: Germline brca2 sequence variants in patients with ocular melanoma. Int J Cancer 82:325-328, 1999 (Pubitemid 29302971)
13. Iscovich J, Abdulrazik M, Cour C, et al: Prevalence of the BRCA2 6174 del T mutation in Israeli uveal melanoma patients. Int J Cancer 98:42-44, 2002 (Pubitemid 34113416)
14. Miki Y, Swensen J, Shattuck-Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994 (Pubitemid 24345325)
15. Wooster R, Bignell G, Lancaster J, et al: Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792, 1995 (Pubitemid 26004412)
16. Murphy CG, Moynahan ME: BRCA gene structure and function in tumor suppression: A repair-centric perspective. Cancer J 16:39-47, 2010
17. Huen MS, Sy SM, Chen J: BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol 11:138-148, 2010
18. Jackson SP, Bartek J: The DNA-damage response in human biology and disease. Nature 461:1071-1078, 2009
19. Ford D, Easton DF, Bishop DT, et al: Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343:692-695, 1994 (Pubitemid 24087847)
20. Harbour JW, Onken MD, Roberson ED, et al: Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330:1410-1413, 2010
21. Jensen DE, Proctor M, Marquis ST, et al: BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 16:1097-1112, 1998 (Pubitemid 28127509)
22. Nishikawa H, Wu W, Koike A, et al: BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity. Cancer Res 69:111-119, 2009
23. Scott RJ, Vajdic CM, Armstrong BK, et al: BRCA2 mutations in a population-based series of patients with ocular melanoma. Int J Cancer 102:188-191, 2003
24. Hearle N, Damato BE, Humphreys J, et al: Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma. Invest Ophthalmol Vis Sci 44:458-462, 2003 (Pubitemid 36159685)